Australia markets open in 9 hours 29 minutes

Heron Therapeutics, Inc. (HRTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.5000+0.1800 (+13.64%)
At close: 04:00PM EST
1.5000 0.00 (0.00%)
Pre-market: 08:20AM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
122,839
107,672
86,346
88,638
145,968
Cost of revenue
67,847
54,874
46,021
36,189
61,619
Gross profit
54,992
52,798
40,325
52,449
84,349
Operating expenses
Research development
56,004
107,506
130,821
174,533
167,382
Selling general and administrative
119,738
119,950
127,332
106,079
127,661
Total operating expenses
175,742
227,456
258,153
280,612
295,043
Operating income or loss
-120,750
-174,658
-217,828
-228,163
-210,694
Interest expense
-
2,474
2,410
1,901
1,472
Total other income/expenses net
1,882
-7,366
-2,855
885
5,945
Income before tax
-119,704
-182,024
-220,683
-227,278
-204,749
Income from continuing operations
-119,704
-182,024
-220,683
-227,278
-204,749
Net income
-119,704
-182,024
-220,683
-227,278
-204,749
Net income available to common shareholders
-119,704
-182,024
-220,683
-227,278
-204,749
Basic EPS
-1.12
-1.67
-2.24
-2.50
-2.50
Diluted EPS
-1.12
-1.67
-2.24
-2.50
-2.50
Basic average shares
117,486
108,876
98,471
90,774
81,779
Diluted average shares
117,486
108,876
98,471
90,774
81,779